In addition, we operated 121 freestanding surgery centers and 21 freestanding endoscopy centers. At December 31, 2020, we operated 185 hospitals, comprised of 178 general, acute care hospitals five psychiatric hospitals and two rehabilitation hospitals. is one of the leading health care services companies in the United States. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities Selected Financial Data Management's Discussion and Analysis of Financial Condition and Results of Operations Quantitative and Qualitative Disclosures about Market Risk Financial Statements and Supplementary Data Changes in and Disagreements with Accountants on Accounting and Financial Disclosure Controls and Procedures Other Informationĭirectors, Executive Officers and Corporate Governance Executive Compensation Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters Certain Relationships and Related Transactions, and Director Independence Principal Accountant Fees and ServicesĮxhibits and Financial Statement Schedules Form 10-K Summary Signatures Item 16.īusiness Risk Factors Unresolved Staff Comments Properties Legal Proceedings Mine Safety Disclosures Table of Contents Index to Financial Statements Portions of the Registrant's definitive proxy materials for its 2021 Annual Meeting of Stockholders are incorporated by reference into Part III hereof.
For purposes of the foregoing calculation only, Hercules Holding II and the Registrant's directors and executive officers have been deemed to be affiliates. As of June 30, 2020, the aggregate market value of the common stock held by nonaffiliates was approximately $25.836 billion. Yes NoĪs of January 31, 2021, there were 339,917,500 outstanding shares of the Registrant's common stock. Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Indicate by check mark whether the Registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act. Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Securities Registered Pursuant to Section 12(g) of the Act: None Name of Each Exchange on Which Registered Title of Each Class Common Stock, $0.01 Par Value
Securities Registered Pursuant to Section 12(b) of the Act: Registrant's telephone number, including area code: (615) 344-9551 One Park Plaza Nashville, Tennessee (Address of Principal Executive Offices)Ģ7-3865930 (I.R.S. (Exact Name of Registrant as Specified in its Charter)ĭelaware (State or Other Jurisdiction of Incorporation or Organization) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSIONĪNNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934įor the fiscal year ended December 31, 2020 File Info : application/pdf, 294 Pages, 1.45MB Document Document f6d377d5-5458-4955-beb4-c5ed6c598c45 Table of Contents Index to Financial Statements
0 kommentar(er)
